GO:0070316 regulation of G0 to G1 transition: Quiescence Exit, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070316 describes the biological process that modulates the rate or extent of the transition from the G0 quiescent state to the G1 phase of the cell cycle.
• The G0-to-G1 transition is driven by growth factors, mitogens, and signaling cascades that activate cyclin D-CDK4/6 and downstream E2F-dependent transcription [1, 5, 6].
• NF-kappaB and D-type cyclins are key regulators that link extracellular signals to cell cycle re-entry [1, 5, 6].
• Dysregulation of G0-to-G1 transition is implicated in cancer, fibrosis, and other proliferative disorders [2, 3, 5].
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal dissection of G0-to-G1 regulators.
• Methods such as flow cytometry, RNA-seq, and proteomics are standard for studying this transition.
Description
The transition from quiescence (G0) to the first gap phase (G1) is a fundamental decision point in cell cycle biology. GO:0070316, regulation of G0 to G1 transition, encompasses the cellular processes that modulate the rate or extent of this switch. This process is critical for tissue homeostasis, regeneration, and immune responses, and its dysregulation underlies diseases such as cancer and fibrosis [2, 3, 5]. Understanding how cells exit quiescence is essential for developing therapies that target proliferative disorders. The G0-to-G1 transition is triggered by extracellular cues, including growth factors and mitogens, which activate intracellular signaling pathways. Key molecular players include NF-kappaB, D-type cyclins, and cyclin-dependent kinases, which together coordinate the transcriptional and post-translational events required for cell cycle re-entry [1, 5, 6]. This article synthesizes authoritative QuickGO data and verified PubMed literature to provide a research-grade overview of GO:0070316, covering its definition, mechanisms, key genes, disease relevance, and experimental approaches.
regulation of G0 to G1 transition At A Glance
| GO ID | GO:0070316 |
|---|---|
| GO term | regulation of G0 to G1 transition |
| Ontology | biological_process |
| Synonym | none |
| Major function | Modulates the rate or extent of the transition from G0 quiescent state to G1 phase |
| Related processes | Cell cycle, G1/S transition, quiescence exit |
| Key regulators | NF-kappaB, cyclin D1, CDK4/6, E2F1 |
| Disease relevance | Cancer, fibrosis, proliferative disorders |
What Is GO:0070316?
According to QuickGO, GO:0070316 (regulation of G0 to G1 transition) is a biological process defined as a cell cycle process that modulates the rate or extent of the transition from the G0 quiescent state to the G1 phase. In other words, it includes all molecular events that control whether, when, and how quickly a quiescent cell re-enters the active cell cycle.
Why Is regulation of G0 to G1 transition Important in Cell Biology?
Regulation of the G0-to-G1 transition is a central control point for cell proliferation and tissue homeostasis. Its dysregulation can lead to uncontrolled cell division in cancer or impaired regeneration in degenerative diseases. Understanding this process provides insights into how cells respond to growth signals and how therapeutic interventions can modulate quiescence exit [2, 3, 5].
• Controls whether quiescent cells re-enter the cell cycle, impacting tissue regeneration and repair.
• Dysregulation is linked to cancer, where cells escape quiescence and proliferate uncontrollably.
• NF-kappaB activation during G0-to-G1 transition is a key early event in growth control.
• Cyclin D1 expression and CDK4/6 activity are critical for G0-to-G1 progression and are targets in cancer therapy [1, 5].
• The transition is modulated by signaling pathways such as ERK1/2 and Wnt/beta-catenin [2, 4].
• Understanding this process aids in developing therapies for proliferative disorders and fibrosis.
• It is essential for immune cell activation and differentiation.
• Experimental models using CRISPR can dissect causal roles of specific genes in this transition.
• Flow cytometry and transcriptomics are standard methods to study G0-to-G1 dynamics.
• The process is conserved across cell types, making findings broadly relevant.
What Happens During regulation of G0 to G1 transition?
Growth Factor Sensing and Early Signaling
In simple terms: Cells first check for external growth signals before deciding to divide.
Quiescent cells in G0 respond to mitogens and growth factors such as IGF-1, which activate receptor tyrosine kinases and downstream cascades including ERK1/2. This signaling leads to the activation of transcription factors like NF-kappaB, which is induced during the G0-to-G1 transition in mouse fibroblasts. NF-kappaB then regulates the expression of cyclin D1, a key mediator of cell cycle re-entry. In multiple myeloma cells, ClC-3 is required for IGF-1-induced G0/G1 to S phase transition via the ERK1/2-cyclins cascade.
Transcriptional Activation of Cyclin D and CDKs
In simple terms: The cell starts producing proteins that push it into the division cycle.
NF-kappaB directly regulates cyclin D1 expression, which partners with CDK4/6 to phosphorylate RB, leading to E2F release and G1 progression. D-type cyclins also have CDK-independent roles in regulating DNA mismatch repair, highlighting their multifunctional nature. In mesangial cells, E2F1 regulates the G1/S transition, a downstream event of G0-to-G1 progression.
ERK1/2 and Cyclin Cascade
In simple terms: A kinase relay helps amplify the growth signal to drive cell cycle entry.
The ERK1/2 pathway is activated by growth factors and contributes to the expression of cyclins, including cyclin D and cyclin E, which promote G0/G1 to S phase transition. In multiple myeloma cells, ClC-3 is required for IGF-1-induced transition via ERK1/2-cyclins cascade. This cascade integrates extracellular signals with the core cell cycle machinery.
NF-kappaB and Inflammatory Signaling
In simple terms: Inflammatory signals can also influence whether a cell exits quiescence.
NF-kappaB is a transcription factor that regulates genes involved in inflammation, immunity, and cell proliferation. Its DNA-binding activity is induced during the G0-to-G1 transition in mouse fibroblasts. NF-kappaB function in growth control includes regulation of cyclin D1 expression and G0/G1-to-S-phase transition. This links inflammatory signaling to cell cycle re-entry.
Viral and Oncogenic Modulation
In simple terms: Some viruses and oncogenes can force quiescent cells to divide.
Epstein-Barr virus transactivators Zta and Rta promote G0/G1 to S transition in Raji cells, illustrating how viral proteins can hijack cell cycle regulation. This highlights the importance of G0-to-G1 transition in viral pathogenesis and cancer.
Key Genes Involved in GO:0070316 regulation of G0 to G1 transition
The following genes and proteins are key regulators of the G0-to-G1 transition, as supported by verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NFKB1 | Transcription factor regulating cyclin D1 and G0/G1-to-S transition | Central to growth control and inflammation [5, 6] |
| CCND1 | Cyclin D1, partners with CDK4/6 to phosphorylate RB | Key mediator of G0-to-G1 progression [1, 5] |
| CDK4 | Cyclin-dependent kinase 4, drives G1 progression | Target in cancer therapy |
| CDK6 | Cyclin-dependent kinase 6, drives G1 progression | Target in cancer therapy |
| E2F1 | Transcription factor regulating G1/S transition | Downstream effector of G0-to-G1 |
| CLCN3 | Chloride channel, required for IGF-1-induced transition | Modulates ERK1/2-cyclins cascade |
| ARG2 | Arginase 2, knockdown promotes G0/G1 arrest | Linked to adenomyosis via NF-kappaB and Wnt |
| IGF1 | Growth factor that induces G0/G1 to S transition | Upstream signal for cell cycle re-entry |
| MAPK1 | ERK2, kinase in ERK1/2 cascade | Mediates growth factor signaling |
| MAPK3 | ERK1, kinase in ERK1/2 cascade | Mediates growth factor signaling |
| RB1 | Retinoblastoma protein, phosphorylated by CDK4/6 | Gatekeeper of G1 progression |
| ZTA | Epstein-Barr virus transactivator | Promotes G0/G1 to S transition |
| RTA | Epstein-Barr virus transactivator | Promotes G0/G1 to S transition |
| WNT | Wnt signaling pathway | Regulates G0/G1 arrest in adenomyosis |
| CTNNB1 | Beta-catenin, Wnt signaling effector | Modulates G0/G1 transition |
How Is regulation of G0 to G1 transition Regulated?
The G0-to-G1 transition is regulated by a complex network of extracellular signals and intracellular pathways. Growth factors such as IGF-1 activate receptor tyrosine kinases, leading to ERK1/2 activation and cyclin expression. NF-kappaB is induced during this transition and regulates cyclin D1 [5, 6]. D-type cyclins, in addition to their CDK-dependent roles, have CDK-independent functions in DNA mismatch repair. The Wnt/beta-catenin pathway also modulates this transition, as ARG2 knockdown promotes G0/G1 arrest via NF-kappaB and Wnt signaling. Viral proteins like Zta and Rta can bypass normal regulatory checkpoints to promote S phase entry.
regulation of G0 to G1 transition and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CCND1 | Cancer (overexpression drives proliferation) | Knockout or overexpression in cancer cell lines |
| NFKB1 | Cancer, inflammation | Knockout in fibroblasts or immune cells |
| CLCN3 | Multiple myeloma | Knockout in myeloma cell lines |
| ARG2 | Adenomyosis | Knockdown or knockout in endometrial cells |
| E2F1 | Mesangial proliferative disorders | Knockout in mesangial cells |
Cancer
Dysregulation of the G0-to-G1 transition is a hallmark of cancer. Overexpression of cyclin D1 or activation of NF-kappaB can drive uncontrolled proliferation [1, 5]. In multiple myeloma, ClC-3 is required for IGF-1-induced transition, suggesting potential therapeutic targets. E2F1 regulation of G1/S transition is also implicated in mesangial cell proliferation.
Adenomyosis and Fibrotic Disorders
ARG2 knockdown promotes G0/G1 cell cycle arrest and mitochondrial dysfunction in adenomyosis via NF-kappaB and Wnt/beta-catenin signaling. This highlights the role of G0-to-G1 transition in benign proliferative disorders.
Viral Pathogenesis
Epstein-Barr virus transactivators Zta and Rta promote G0/G1 to S transition, contributing to viral replication and potentially oncogenesis. This demonstrates how pathogens can manipulate the host cell cycle.
From regulation of G0 to G1 transition-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate G0-to-G1 transition? | CRISPR knockout in cell lines followed by flow cytometry |
| Does a specific point mutation in gene X affect transition? | CRISPR point mutation knock-in |
| Does overexpression of gene X drive quiescence exit? | CRISPR overexpression (e.g., CRISPRa) or lentiviral overexpression |
| Does tagging gene X affect its function? | CRISPR knock-in of epitope tag |
| Which genes are essential for G0-to-G1? | CRISPR library screening |
| What are the transcriptomic changes during transition? | RNA-seq of synchronized cells |
How to Study the regulation of G0 to G1 transition Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Cell cycle distribution (G0/G1, S, G2/M) | Quantify transition after gene knockout |
| RNA-seq | Transcriptional changes | Identify genes upregulated during transition |
| Proteomics | Protein abundance and modifications | Measure cyclin D1 and CDK activity |
| CRISPR knockout screening | Essential genes for transition | Genome-wide discovery |
| CRISPR activation screening | Genes whose overexpression drives transition | Identify drivers of quiescence exit |
| Western blot | Protein expression and phosphorylation | Validate specific pathway activation |
| Immunofluorescence | Subcellular localization and proliferation markers | Visualize transition in situ |
| EdU incorporation | DNA synthesis (S phase entry) | Measure G0-to-S transition |
Flow Cytometry
Flow cytometry with DNA dyes (e.g., propidium iodide) and proliferation markers (e.g., Ki-67) is used to quantify the proportion of cells in G0/G1 versus S/G2/M phases. This method is standard for assessing G0-to-G1 transition after genetic perturbations [2, 4].
RNA Sequencing
RNA-seq of synchronized cells at different time points after growth factor stimulation can identify transcriptional programs activated during G0-to-G1 transition. This includes upregulation of cyclins and NF-kappaB target genes [5, 6].
Proteomics
Mass spectrometry-based proteomics can measure changes in protein abundance and post-translational modifications during the transition. For example, cyclin D1 levels and CDK4/6 activity can be monitored.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens can identify genes that regulate G0-to-G1 transition. Cells are synchronized in G0, then screened for those that fail to re-enter G1 upon stimulation.
How CRISPR Can Be Used to Study GO:0070316 regulation of G0 to G1 transition
Knockout
CRISPR knockout of candidate genes (e.g., NFKB1, CCND1, CLCN3) in cell lines followed by synchronization and stimulation can determine whether the gene is required for G0-to-G1 transition. Flow cytometry and proliferation assays are used to quantify effects [2, 4].
Point Mutation
CRISPR point mutation knock-in can introduce specific amino acid changes to dissect functional domains. For example, mutating phosphorylation sites in cyclin D1 or NF-kappaB can reveal their role in transition [1, 5].
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins allows tracking of endogenous protein localization and interactions during G0-to-G1 transition. This is useful for studying dynamic changes in protein complexes.
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression can force expression of candidate genes to test whether they are sufficient to drive quiescence exit. For example, overexpressing cyclin D1 or NF-kappaB can promote transition [5, 6].
How EDITGENE Supports regulation of G0 to G1 transition Research
Researchers studying regulation of G0 to G1 transition-related genes often need to determine whether a candidate gene is causally involved in quiescence exit or simply correlated with proliferation. EDITGENE provides a comprehensive suite of CRISPR services to enable such causal studies.
Contact EDITGENE today to design your custom CRISPR model for regulation of G0 to G1 transition research.
Frequently Asked Questions About regulation of G0 to G1 transition
What is GO:0070316?
GO:0070316 is the Gene Ontology term for regulation of G0 to G1 transition, a biological process that modulates the rate or extent of the transition from the G0 quiescent state to the G1 phase.
What genes are involved in regulation of G0 to G1 transition?
Key genes include NFKB1, CCND1, CDK4, CDK6, E2F1, CLCN3, ARG2, and IGF1, among others [1, 2, 3, 4, 5, 6].
How is the G0 to G1 transition regulated?
It is regulated by growth factors, signaling cascades such as ERK1/2 and NF-kappaB, and cyclin-CDK complexes that phosphorylate RB and activate E2F [1, 4, 5, 6].
What diseases are associated with dysregulation of G0 to G1 transition?
Cancer, adenomyosis, and viral pathogenesis are linked to dysregulation of this transition [2, 4, 5, 8].
What methods are used to study G0 to G1 transition?
Flow cytometry, RNA-seq, proteomics, and CRISPR screening are commonly used [2, 4, 5].
How can CRISPR be used to study G0 to G1 transition?
CRISPR knockout, point mutation, knock-in, and overexpression can be used to dissect gene function in this transition [1, 2, 4, 5].
What is the role of NF-kappaB in G0 to G1 transition?
NF-kappaB is induced during the transition and regulates cyclin D1 expression, promoting G0/G1-to-S phase progression [5, 6].
What is the role of cyclin D1 in G0 to G1 transition?
Cyclin D1 partners with CDK4/6 to phosphorylate RB, leading to E2F release and G1 progression [1, 5].
How does ARG2 affect G0/G1 transition?
ARG2 knockdown promotes G0/G1 cell cycle arrest and mitochondrial dysfunction in adenomyosis via NF-kappaB and Wnt signaling.
What is the significance of ClC-3 in multiple myeloma?
ClC-3 is required for IGF-1-induced G0/G1 to S phase transition via ERK1/2-cyclins cascade in multiple myeloma cells.
Conclusion
Regulation of the G0 to G1 transition (GO:0070316) is a critical cell cycle process that controls quiescence exit and proliferation. Key regulators include NF-kappaB, cyclin D1, CDK4/6, and E2F1, which integrate growth factor signals to drive cell cycle re-entry. Dysregulation of this process is implicated in cancer, adenomyosis, and viral pathogenesis. CRISPR-based models and advanced methods such as flow cytometry and RNA-seq are essential for dissecting the molecular mechanisms. EDITGENE offers comprehensive services to support research in this field.
References
- 1. Rona G et al.. 2024. CDK-independent role of D-type cyclins in regulating DNA mismatch repair.. Mol Cell 84(7):1224-1242.e13 PMID: 38458201
- 2. Xu Y et al.. 2024. ARG2 knockdown promotes G0/G1 cell cycle arrest and mitochondrial dysfunction in adenomyosis via regulation NF-κB and Wnt/Β-catenin signaling cascades.. Int Immunopharmacol 140:112817 PMID: 39116499
- 3. Inoshita S et al.. 1999. Regulation of the G1/S transition phase in mesangial cells by E2F1.. Kidney Int 56(4):1238-41 PMID: 10504464
- 4. Du Y et al.. 2018. Requirement of ClC-3 in G0/G1 to S Phase Transition Induced by IGF-1 via ERK1/2-Cyclins Cascade in Multiple Myeloma Cells.. Clin Lab 64(6):929-936 PMID: 29945325
- 5. Hinz M et al.. 1999. NF-kappaB function in growth control: regulation of cyclin D1 expression and G0/G1-to-S-phase transition.. Mol Cell Biol 19(4):2690-8 PMID: 10082535
- 6. Baldwin AS Jr et al.. 1991. Induction of NF-kappa B DNA-binding activity during the G0-to-G1 transition in mouse fibroblasts.. Mol Cell Biol 11(10):4943-51 PMID: 1922027
- 8. Guo Q et al.. 2010. Transactivators Zta and Rta of Epstein-Barr virus promote G0/G1 to S transition in Raji cells: a novel relationship between lytic virus and cell cycle.. Mol Immunol 47(9):1783-92 PMID: 20338640
